The Biggest Myth About Cardiovascular Prevention

35 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
At ASPC 2025, Dr. Harpreet Bhatia (Assistant Professor of Medicine at UC San Diego Health) addresses one of the most persistent myths in cardiovascular prevention, that there is no need to test for lipoprotein(a) because it cannot be treated.

In this interview, you will learn:

Why Lp (a) testing is critical despite the lack of direct therapy today
How identifying elevated Lp(a) can guide aggressive management of other risk factors
Why early detection can improve precision in cardiovascular risk assessment
How future therapies may directly target Lp(a)

Connect with Dr. Harpreet Bhatia:
https://www.linkedin.com/in/harpreet-bhatia-b914b817/

Learn more at:
ASPC: https://www.aspconline.org
CardioVisual: https://www.medicalvisual.com

Watch more interviews from ASPC 2025 and subscribe for more clinician-led cardiometabolic insights.
#ASPC2025 #PreventiveCardiology #CardioVisual

Thumbnail Text Ideas
Think You Shouldn’t Test for Lipoprotein (a)? Think again.
Categoria
Cardiology
Commenta per primo questo video.

Prossimo